Table 1 Clinical features of patients in two groups before treatment
Clinical features | No. of patients | p valve | |
|---|---|---|---|
Infusion group (n = 18) | Control group (n = 19) | ||
Median age, years | 21 [11–60] | 29 [17–57] | 0.368 |
Gender, female to male | 5:13 | 6:13 | 0.800 |
Fever | 18 (100%) | 19 (100%) | – |
Splenomegaly/hepatomegaly | 16 (88.9%) | 16 (84.2%) | 0.677 |
Hemophagocytosis | 14 (77.8%) | 14 (73.7%) | 0.772 |
NK cell activity < 15.11% | 6 (33.3%) | 4 (21.1%) | 0.401 |
soluble CD25 > 6400 pg/ml | 14 (77.8%) | 19 (100%) | 0.100 |
EBV-DNA (copies/ml) (at diagnosis) | 5.0 × 105 [1.5 × 103, 7.7 × 107] | 1.0 × 106 [2.0 × 103, 5.2 × 107] | 0.090 |